HBM Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
197
- Portfolio
-
39
- Exits
-
128
HBM Partners General Information
Company Description
Founded in 2001, HBM Partners is a venture capital firm based in Zug, Switzerland. The firm prefers to invest in companies operating in the biopharma and healthcare sectors based in Europe, North America, and India. The firm focuses on venture, growth, and buy-out financings of private companies as well as investments in public companies.
Business Details
Website
www.hbmpartners.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Bundesplatz 1
- 6300 Zug
- Switzerland
HBM Partners Investments (197)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Numab | 09-Jan-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Xcell Biosciences | 14-Jun-2024 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Biopas Group | 31-May-2024 | Pharmaceuticals | Generating Revenue | |||
| Alumis | 29-May-2024 | Drug Discovery | Generating Revenue | |||
| Shape Memory Medical | 04-Mar-2024 | Therapeutic Devices | Generating Revenue | |||
| Hausen Bernstein | 01-Mar-2024 | Distributors/Wholesale | Generating Revenue | |||
| ADARx Pharmaceuticals | 02-Aug-2023 | Biotechnology | Clinical Trials - Phase 1 | |||
| 1000Farmacie | 27-Jul-2023 | Specialty Retail | Generating Revenue | |||
| ArriVent Biopharma | 17-Mar-2023 | Early Stage VC | Pharmaceuticals | Clinical Trials - Phase 3 | ||
| Mahzi Therapeutics | 11-Nov-2022 | Early Stage VC | Drug Discovery | Pre-Clinical Trials |
HBM Partners Exits (128)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Dren Bio | 20-Mar-2025 | Merger/Acquisition | |
| Sai Life Sciences | 18-Dec-2024 | ||
| Gynesonics | 11-Oct-2024 | ||
| Upstream Bio | 11-Oct-2024 | ||
| Alumis | 28-Jun-2024 | ||
| Ambrx | 07-Mar-2024 | ||
| ArriVent Biopharma | 26-Jan-2024 | ||
| IVERIC bio | 11-Jul-2023 | ||
| Mineralys | 09-Feb-2023 | IPO | |
| Cardialen | 14-Dec-2022 | Merger/Acquisition |
HBM Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
HBM Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
HBM Partners Co-Investors (218)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HBM Healthcare Investments | 30 |
|
|
||
| Cormorant Asset Management |
|
|
|||
| Samsara BioCapital |
|
|
|||
| The Invus Group |
|
|
|||
| OrbiMed |
|
|
HBM Partners Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| HBM Healthcare Investments | Zug, Switzerland | 2001 |
HBM Partners FAQs
-
What is HBM Partners?
Founded in 2001, HBM Partners is a venture capital firm based in Zug, Switzerland.
-
When was HBM Partners founded?
HBM Partners was founded in 2001.
-
Where is HBM Partners headquartered?
HBM Partners is headquartered in Zug, Switzerland.
-
What is HBM Partners's total asset value?
HBM Partners has around in total assets under management.
-
How many investments has HBM Partners made?
HBM Partners has made 197 investments.
-
What has HBM Partners invested in?
HBM Partners has made numerous investments in companies like Numab, Xcell Biosciences, and Biopas Group within the Drug Discovery, Discovery Tools (Healthcare), and Pharmaceuticals industries.
-
What has HBM Partners invested in recently?
HBM Partners's latest investment was on 09-Jan-2025 in Numab, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
